urinary%20tract%20infection%20in%20women%20-%20complicated
URINARY TRACT INFECTION IN WOMEN - COMPLICATED
Complicated urinary tract infection (UTI) is associated with a condition [eg structural or functional abnormalities of the genitourinary tract (GUT)] or the presence of an underlying disease that interferes with host defense mechanisms, which increases the risks of acquiring infection, failing therapy or having recurrent infections. The successful treatment of a complicated UTI considers effective antimicrobial therapy, optimal management of the underlying abnormalities or other diseases and adequate life-supporting measures.

Urinary%20tract%20infection%20in%20women%20-%20complicated Signs and Symptoms

Definition

  • Complicated urinary tract infection (UTI) is associated with a condition [eg structural or functional abnormalities of the genitourinary tract (GUT)] or the presence of an underlying disease that interferes with host defense mechanisms, which increases the risks of acquiring infection, failing therapy or having recurrent infections
  • Associated with altered microbiology that favors more antimicrobial-resistant strains that are sometimes less virulent than those found in uncomplicated UTI

Etiology

  • The spectrum of bacteria causing complicated UTI is much larger than that of uncomplicated UTI and more likely to be antibiotic-resistant
    • Escherichia coli, Proteus, Klebsiella, Pseudomonas, Serratia spp and enterococci are the usual strains found in urine culture
  • Catheter-associated UTI
    • Short-term (<1 week): E coli, Pseudomonas aeruginosa
    • Long-term (>1 week): Proteus mirabilis, E coli, P aeruginosa, Providencia stuartii, Morganella morganii, Citrobacter sp, Enterobacter sp, Enterococcus sp, Candida spp
  • Diabetes mellitus (DM) patients: E coli, Klebsiella pneumoniae, P mirabilis, P aeruginosa, Enterobacter sp, Enterococcus sp, Candida spp
  • Renal transplant patients: E coli, P mirabilis, K pneumoniae, P aeruginosa, Gram-positive cocci, Enterobacter sp, Enterococci sp, Serratia sp, Acinetobacter sp, Citrobacter spp, Corynebacterium urealyticum
  • Neutropenic patients: Gram-negative bacilli especially P aeruginosa, Staphylococcus aureus, Candida sp 
  • Patients with anatomic abnormalities: E coli, K pneumoniae, P aeruginosa, P mirabilis

Signs and Symptoms

  • A complicated UTI does not necessarily present with clinical symptoms
  • Dysuria, urgency, frequency, flank pain, costovertebral angle tenderness, suprapubic pain and fever may or may not be present
  • May present with signs of sepsis: Hypotension, temperature >40°C, tender subcostal or intractable nausea and vomiting
  • Symptoms may vary from severe obstructive acute pyelonephritis with imminent urosepsis to a catheter-associated post-operative UTI
  • Concomitant medical conditions (DM, renal failure) are often present

Risk Factors

Factors that Suggest a Potential Complicated UTI:

  • >7 days of symptoms prior to presentation
  • Azotemia due to intrinsic renal disease
  • Chemical or radiation injuries of the uroepithelium
  • Comorbidities that predispose to papillary necrosis (eg sickle cell disease, severe DM, analgesic abuse, Pseudomonas sp infection]
  • Elderly
  • Pregnancy
  • Healthcare-associated or hospital-acquired infection
  • Immunosuppression
  • Incomplete bladder emptying with >100 mL of residual urine
  • Obstructive uropathy (eg bladder outlet obstruction, calculi, stones, stricture, tumor)
  • Peri- and postoperative UTI
  • Presence of an indwelling urinary catheter or use of intermittent bladder catheterization
  • Recent antimicrobial use
  • Recent urinary tract intervention or instrumentation
  • Renal insufficiency and transplantation
  • Unresolved UTI due to failed response to antibiotic therapy
  • Urinary tract modifications (eg ileal loop or pouch)
  • Vesicoureteral reflux or other functional abnormalities
  • Residence in an institution providing extended care
  • Foreign body 
  • Isolated extended-spectrum beta-lactamase (ESBL)-producing or multidrug-resistant organisms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.